Company / Accounts Receivable
NeuroPace Inc Accounts Receivable History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Accounts Receivable
$14.7M
FY2025
5-year range
$7.1M / $14.7M
FY2021-FY2025
Trend
+14.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Accounts Receivable has increased for 4 consecutive years, from $7M in FY2021 to $15M in FY2025.
Based on SEC 10-K filings.
$15M in FY2025 with a 3-year CAGR of +25.2%.
Improved from $12M to $15M over the past 2 years.
Accounts Receivable over time
Growth rates
- 3-Year CAGR
- +25.2%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- NeuroPace Inc's accounts receivable has grown for 4 consecutive years.
- 3-year CAGR of +25.2%, indicating consistent growth.
- In FY2025, accounts receivable increased 14.2% year-over-year.
- Lowest accounts receivable in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score 0.67 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Accounts ReceivableValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $14.7M | +14.2% |
| FY2024 | $12.9M | +4.4% |
| FY2023 | $12.3M | +64.6% |
| FY2022 | $7.5M | +5.5% |
| FY2021 | $7.1M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026